Bharat Biotech on Tuesday announced the Covaxin power expansion to encourage vaccination campaigns in India and internationally amid the spike in COVID-19 cases. Currently, Hyderabad-based Bharat Biotech is currently producing 4 million doses of Covaxin monthly, whereas Pune-based Serum Institute of India (SII) is producing 60 million doses of Covishield.
Disclaimer: Prre.site is not liable for any damages arising from the use of this website or its content.
